# Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen

> **NCT07137039** · PHASE2 · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 34 (estimated)

## Conditions studied

- Locally Advanced Hypopharyngeal Cancer

## Interventions

- **DRUG:** Adebrelimab+Albumin paclitaxel +Cisplatin

## Key facts

- **NCT ID:** NCT07137039
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-20
- **Primary completion:** 2027-08-20
- **Final completion:** 2028-08-20
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07137039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07137039, "Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT07137039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*